News Click, Boehringer DTx for schizophrenia passes phase 3 test Click and Boehringer Ingelheim make progress in software-enhanced drug treatment for schizophrenia with a positive phase 3 trial of their CT-155 app.
News Strand raises $153m for RNA meds, and other bio financings Recent financings in biotech include a $153m Series B for programmable mRNA developer Strand, plus rounds for Artbio, Minghui, and Chai Discovery.
News Meta harvested health data to target ads, jury concludes A jury in the US found that Meta illegally invaded the privacy of users of a health app, with implications for how tech firms handle personal data.
News Noom expands its GLP-1 range with 'microdose' package Noom is offering 'microdoses' of semaglutide at a knock-down price, claiming they can prevent side effects but remain effective for weight loss.
News ChatGPT can cut review times for clinical trial eligibility ChatGPT can't replace humans when it comes to checking patient eligibility to take part in clinical trials, but it can save time and money.
News Tech giants back unified health data-sharing platform in US The Trump administration wants to build an interoperable digital health platform for handling patient records, medical systems, and apps.
News GSK to file Jemperli for rectal cancer after phase 3 readout GSK's pivotal AZUR-1 trial of Jemperli monotherapy to delay or eliminate surgery in pre-operative rectal cancer has delivered a positive result.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.